Jakob Lauritsen
Papers
1
Total Citations
14
H-Index
1
About
Jakob Lauritsen is a leading clinical researcher in the field of testicular cancer, with a specific focus on non-seminomatous germ cell tumours (NSGCT). His work centers on optimizing post-chemotherapy surgical management, particularly retroperitoneal lymph node dissection (RPLND). His most-cited systematic review, published in 2021, provides a comprehensive analysis of oncological outcomes and complications following post-chemotherapy retroperitoneal surgery, offering critical guidance for urologists and oncologists managing patients with residual retroperitoneal masses. This work has accumulated 14 citations, underscoring its influence in shaping evidence-based surgical protocols. Lauritsen’s research addresses the delicate balance between achieving complete tumour resection and minimizing surgical morbidity, a key challenge in advanced testicular cancer care. His contributions are vital for improving survival rates and quality of life in young men with this disease, and his systematic review remains a cornerstone reference for clinicians navigating complex post-chemotherapy treatment decisions.
Research Focus
Key Achievements
Top Papers
- 1